| [1] |
Dalmau J, Tüzün E, Wu HY, et al. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma[J]. Ann Neurol, 2007, 61(1): 25-36.
|
| [2] |
Dalmau J, Gleichman AJ, Hughes EG, et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies[J]. Lancet Neurol, 2008, 7(12): 1091-1098.
|
| [3] |
刘美云，谢琰臣，李继梅. 抗NMDA受体脑炎[J]. 中国神经免疫学和神经病学杂志，2010, 17(6): 449-451.
|
| [4] |
王得新，刘磊. 自身免疫性脑炎现代概念与分类[J]. 中国实用内科杂志，2012, 32(11): 824-825.
|
| [5] |
Mann AP, Grebenciucova E, Lukas RV. Anti-N-methyl-D-aspartate-receptor encephalitis: diagnosis, optimal management, and challenges[J]. Ther Clin Risk Manag, 2014, 10: 517-525.
|
| [6] |
袁馨，赵霞. 伴有卵巢成熟性畸胎瘤的抗NMDA受体脑炎1例[J]. 实用妇产科杂志，2016, 32(4): 302-304.
|
| [7] |
Vitaliani R, Mason W, Ances B, et al. Paraneoplastic encephalitis, psychiatric symptoms, and hypoventilation in ovarian teratoma[J]. Ann Neurol, 2005, 58(4): 594-604.
|
| [8] |
乔娜娜. 儿童抗N-甲基-D-天冬氨酸受体抗体脑炎[J]. 国际儿科学杂志，2013, 40(5): 481-485.
|
| [9] |
Tüzün E, Zhou L, Baehring JM, et al. Evidence for antibody-mediated pathogenesis in anti-NMDAR encephalitis associated with ovarian teratoma[J]. Acta Neuropathol, 2009, 118(6): 737-743.
|
| [10] |
Titulaer MJ, McCracken L, Gabilondo I, et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study[J]. Lancet Neurol, 2013, 12(2): 157-165.
|
| [11] |
Iizuka T, Sakai F, Ide T, et al. Anti-NMDA receptor encephalitis in Japan: long-term outcome without tumor removal[J]. Neurology, 2008, 70(7): 504-511.
|
| [12] |
Dalmau J, Lancaster E, Martinez-Hernandez E, et al. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis[J]. Lancet Neurol, 2011, 10(1): 63-74.
|
| [13] |
Kayser MS, Titulaer MJ, Gresa-Arribas N, et al. Frequency and characteristics of isolated psychiatric episodes in anti-N-methyl-D-aspartate receptor encephalitis[J]. JAMA Neurol, 2013, 70(9): 1133-1139.
|
| [14] |
Seki M, Suzuki S, Iizuka T, et al. Neurological response to early removal of ovarian teratoma in anti-NMDAR encephalitis[J]. J Neurol Neurosurg Psychiatr, 2008, 79(3): 324-326.
|
| [15] |
Clark RM, Lynch MP, Kolp R, et al. The N-methyl-D-aspartate receptor, a precursor to N-methyl-D-aspartate receptor encephalitis, is found in the squamous tissue of ovarian teratomas[J]. Int J Gynecol Pathol, 2014, 33(6): 598-606.
|
| [16] |
Boeck AL, Logemann F, Krauβ T, et al. Ovarectomy despite negative imaging in anti-NMDA receptor encephalitis: effective even late[J]. Case Rep Neurol Med, 2013, 2013: 843192.
|
| [17] |
Tanyi JL, Marsh EB, Dalmau J, et al. Reversible paraneoplastic encephalitis in three patients with ovarian neoplasms[J]. Acta Obstet Gynecol Scand, 2012, 91(5): 630-634.
|
| [18] |
郎宇，王天龙，吴岚，等. 抗NMDA受体脑炎患者行卵巢畸胎瘤切除术的麻醉管理[J]. 麻醉学大查房，2013, 4(2): 119-125.
|
| [19] |
Kawano H, Hamaguchi E, Kawahito S, et al. Anaesthesia for a patient with paraneoplastic limbic encephalitis with ovarian teratoma: relationship to anti-N-methyl-D-aspartate receptor antibodies[J]. Anaesthesia, 2011, 66(6): 515-518.
|
| [20] |
Pryzbylkowski PG, Dunkman WJ, Liu R, et al. Case report: anti-N-methyl-D-aspartate receptor encephalitis and its anesthetic implications[J]. Anesth Analg, 2011, 113(5): 1188-1191.
|
| [21] |
Gao XR, Liao ZM, Luo LL, et al. The use of epidural anesthesia in excision of ovarian teratoma associated with anti-N-methyl-D-aspartate receptor encephalitis: a case report[J]. Int J Clin Exp Med, 2016, 9(8): 16927-16929.
|
| [22] |
Chaw SH, Foo LL, Chan L, et al. Anesthesia in anti-N-methyl-D-aspartate receptor encephalitis - is general anesthesia a requisite? A case report[J]. Rev Bras Anestesiol, 2016, 16: 3.
|
| [23] |
Orser BA, Pennefather PS, MacDonald JF. Multiple mechanisms of ketamine blockade of N-methyl-D-aspartate receptors[J]. Anesthesiology, 1997, 86(4): 903-917.
|
| [24] |
Kohrs R, Durieux ME. Ketamine: teaching an old drug new tricks[J]. Anesth Analg, 1998, 87(5): 1186-1193.
|
| [25] |
Olney JW, Labruyere J, Price MT. Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs[J]. Science, 1989, 244(4910): 1360-1362.
|
| [26] |
Nishikawa K, MacIver MB. Excitatory synaptic transmission mediated by NMDA receptors is more sensitive to isoflurane than are non-NMDA receptor-mediated responses[J]. Anesthesiology, 2000, 92(1): 228-236.
|
| [27] |
Cheng G, Kendig JJ. Enflurane directly depresses glutamate AMPA and NMDA currents in mouse spinal cord motor neurons independent of actions on GABAA or glycine receptors[J]. Anesth, 2000, 93(4): 1075-1084.
|
| [28] |
Hollmann MW, Liu HT, Hoenemann CW, et al. Modulation of NMDA receptor function by ketamine and magnesium. Part II: interactions with volatile anesthetics[J]. Anesth Analg, 2001, 92(5): 1182-1191.
|
| [29] |
Lapébie FX, Kennel C, Magy L, et al. Potential side effect of propofol and sevoflurane for anesthesia of anti-NMDA-R encephalitis[J]. BMC Anesthesiol, 2014, 14(1): 5.
|
| [30] |
Broderick DK, Raines DE, Nanji KC. Total intravenous anesthesia using N-methyl-D-aspartate (NMDA) receptor-sparing drugs in a patient with anti-NMDA receptor encephalitis[J]. A A Case Rep, 2014, 2(7): 83-85.
|
| [31] |
Liu H, Jian M, Liang F, et al. Anti-N-methyl-D-aspartate receptor encephalitis associated with an ovarian teratoma: two cases report and anesthesia considerations[J]. BMC Anesthesiol, 2015, 15: 150.
|
| [32] |
高兴蓉，罗林丽，罗东. BIS用于抗NMDA受体抗体脑炎患者术中麻醉深度监测1例报告[J]. 四川大学学报(医学版), 2017, 48(1): 172.
|